Earnings Feed
Start Free
|4Jan 14, 2:29 PM ET

Forman Stephen J. 4

4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jan 14, 2021

Insider Transaction Report

Form 4
Period: 2021-01-06
LIXTE BIOTECHNOLOGY HOLDINGS, INC.LIXT
Forman Stephen J.
Director
Transactions
  • Award

    Options to Purchase Common Stock

    2021-01-06+50,000→ 50,000 total
    Exercise: $3.21From: 2021-01-06Exp: 2026-01-06→ Common (50,000 underlying)
Holdings

  • Options to Purchase Common Stock

    Exercise: $6.60From: 2019-05-22Exp: 2024-05-22→ Common (8,333 underlying)
    8,333

  • Options to Purchase Common Stock

    Exercise: $0.96From: 2016-05-13Exp: 2021-05-13→ Common (33,333 underlying)
    33,333

  • Options to Purchase Common Stock

    Exercise: $0.90From: 2017-10-16Exp: 2022-10-16→ Common (8,333 underlying)
    8,333

  • Warrants to Purchase Common Stock

    (indirect: By Trust)
    Exercise: $5.70From: 2018-12-07Exp: 2022-12-07→ Common (21,053 underlying)
    21,053

  • Warrants to Purchase Common Stock

    (indirect: By Trust)
    Exercise: $6.00From: 2018-12-07Exp: 2022-12-07→ Common (16,667 underlying)
    16,667

Documents

1 file
  • 4
    ownership.xmlPrimary